Yujing Wang

Key Laboratory For Drug Evaluation And Clinical Research Of Zhejiang Province, State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Hexachlorobutadiene exposure promotes hepatocellular carcinoma progression via CD8+ T dysfunction and VDR-mediated PI3K/AKT activation: An integrated multi-omics and experimental study.

Hexachlorobutadiene exposure promotes hepatocellular carcinoma progression via CD8+ T dysfunction and VDR-mediated PI3K/AKT activation: An integrated multi-omics and experimental study.

Journal: Ecotoxicology and environmental safety

Published: June 19, 2026

Novel genetic insights into causal effects of depression on non-alcoholic fatty liver diseases partially mediated by gut microbiota.

Novel genetic insights into causal effects of depression on non-alcoholic fatty liver diseases partially mediated by gut microbiota.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: March 06, 2026

Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B.

Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B.

Journal: Alimentary pharmacology & therapeutics

Published: February 02, 2026

Glycodeoxycholic acid inhibits hepatocellular carcinoma by driving M1 polarization of macrophages via the S1PR2-NF-κB-NLRP3 pathway.

Glycodeoxycholic acid inhibits hepatocellular carcinoma by driving M1 polarization of macrophages via the S1PR2-NF-κB-NLRP3 pathway.

Journal: JHEP reports : innovation in hepatology

Published: July 16, 2025

TREM1-mediated macrophage activation drives voriconazole-induced hepatic steatosis: Diagnostic and therapeutic implications.

TREM1-mediated macrophage activation drives voriconazole-induced hepatic steatosis: Diagnostic and therapeutic implications.

Journal: Journal of pharmaceutical analysis

Published: July 05, 2025

NAE1 protein: a prognostic, immunomodulatory, and therapeutic biomarker associated with neddylation in hepatocellular carcinoma.

NAE1 protein: a prognostic, immunomodulatory, and therapeutic biomarker associated with neddylation in hepatocellular carcinoma.

Journal: International journal of biological macromolecules

Published: February 26, 2025

Identification and quantification of the antioxidants in Ginkgo biloba leaf.

Identification and quantification of the antioxidants in Ginkgo biloba leaf.

Journal: Biomedical chromatography : BMC

Published: March 28, 2024

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for Helicobacter pylori infection: a protocol of a single-centre, single-blind, randomised clinical trial in China.

Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for Helicobacter pylori infection: a protocol of a single-centre, single-blind, randomised clinical trial in China.

Journal: BMJ open

Published: July 21, 2023

Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naïve patients: a retrospective observational study.

Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naïve patients: a retrospective observational study.

Journal: BMJ open

Published: September 17, 2022

Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.

Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.

Journal: Helicobacter

Published: August 09, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026